XML 36 R24.htm IDEA: XBRL DOCUMENT v3.22.0.1
15. INCOME TAXES
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
15. INCOME TAXES

15. INCOME TAXES

No provision for income taxes has been recorded for 2021, 2020 and 2019 due to the valuation allowances placed against the net operating losses and deferred tax assets arising during such periods. A valuation allowance has been recorded for all deferred tax assets. Based on our history of losses since inception, the available objective evidence creates sufficient uncertainty regarding the realizability of the deferred tax assets.

The effective tax rate of our provision (benefit) for income taxes differs from the Federal statutory rate as follows:

                   
      Year Ended December 31,
      2021     2020     2019
Statutory rate     21.0%     21.0%     21.0%

Non-deductible executive compensation

    (8.2)%     0.0%     0.0)%

Share-based compensation 

    25.1%     0.0%     0.0)%
Net operating loss expiration     (16.2)%     (47.5)%     (14.7)%
Tax credits     1.4%     2.2%     2.8%
Change in valuation allowance     (23.1)%     24.3%     (9.1)%
Total     0.0%     0.0%     0.0%

 

Deferred tax assets are summarized as follows (in thousands):

             
      December 31,
      2021     2020
Deferred tax assets            
     Reserves   $ 634    $ 647 
     Net operating loss carryforwards     90,593      83,289 
     R&D credit carryforwards     8,984      8,836 
     Depreciation/amortization deferred     17,417      15,862 
     Operating lease liabilities     1,222      296 
     Other     6,701      5,676 
        Total deferred tax assets   125,551      114,606 
Deferred tax liabilities            
     Operating lease right-of-use assets     (1,171)      (199) 
        Total deferred tax liabilites   (1,171)      (199) 
Net valuation allowances     (124,380)     (114,407)
Deferred tax assets   $ -    $ - 

 

At December 31, 2021, we have net operating loss carryforwards of approximately $431.4 million for federal income tax reporting purposes. In addition, we have research and development tax credits of $9.0 million. During 2021, $31.2 million federal net operating losses and $456,000 general business credits expired unused. A majority of the net operating loss carryforwards and research and development credits available to offset future taxable income, if any, will expire in varying amounts from 2022 to 2041, if not previously used.

Certain net operating losses arise from the deductibility for tax purposes of compensation under nonqualified stock options equal to the difference between the fair value of the stock on the date of exercise and the exercise price of the options. For financial reporting purposes, the tax effect of this deduction, when recognized, is accounted for as an income tax benefit.

In certain circumstances, as specified in the Internal Revenue Code, a 50% or more ownership change by certain combinations of our shareholders during any three year period would result in limitations on our ability to use a portion of our net operating loss carryforwards.

We had no unrecognized tax benefits at December 31, 2021 or 2020.

We recognize interest accrued and penalties related to unrecognized tax benefits in tax expense. During the years ended December 31, 2021, 2020 and 2019 we recognized no interest or penalties.

 

We file income tax returns in the U.S. federal jurisdiction and Oregon. Due to our operating loss and credit carryforwards, the U.S. federal statute of limitations remains open for 1998 and onward.